Top Suppliers:I want be here


1147271-25-7

1147271-25-7 structure
1147271-25-7 structure

Name 2-Amino-8-(2-morpholin-4-yl-ethoxy)-4-phenyl-indeno[1,2-d]pyrimidin-5-one
Description JNJ-40255293 is a high-affinity human A 2A receptor antagonist with a KiKi of 7.5 nM. JNJ-40255293 can be used in the research of neurodegenerative diseases such as Parkinson's disease[1].
Related Catalog
In Vivo JNJ-40255293 (0.1-10 mg/kg, p.o.) 可以逆转氟哌啶醇 (HY-14538) 诱导的雄性 Balb/c 小鼠僵直症。在雄性 Wistar 大鼠中,JNJ-40255293 也可以剂量依赖性地逆转氟哌啶醇(0.63 mg/kg,皮下注射)诱导的强直性昏厥,增强主动觉醒,显着逆转利血平(HY-N0480)引起的运动活性缺陷[1]。
References

[1]. John R Atack, et al. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease. ACS Chem Neurosci. 2014 Oct 15;5(10):1005-19.   

Molecular Formula C23H22N4O3
Molecular Weight 402.45
Exact Mass 402.16900
PSA 90.57000
LogP 3.16730